Novo commits USD 200 million over 10 years to support the World Diabetes Foundation to strengthen diabetes prevention and care

Résumé détaillé

Bagsværd, Denmark, 11 November 2026 – Novo Nordisk today announced a USD 200 million commitment to the World Diabetes Foundation (WDF) for 2027–2036. Announced ahead of World…

Bagsværd, Denmark, 11 November 2026 – Novo Nordisk today announced a USD 200 million commitment to the World Diabetes Foundation (WDF) for 2027–2036. Announced ahead of World Diabetes Day (14 November), the funding will support WDF's work to strengthen diabetes prevention and care in low- and middle-income countries, enhancing equitable access for underserved communities.

Diabetes is a growing global health crisis, affecting an estimated 589 million adults worldwide1. It is estimated that around 80% of adults aged 20–79 living with diabetes reside in low- and middle-income countries1. The 10-year commitment will give WDF greater certainty to plan for the long term, to continue to build on its partnerships, and scale regional and global responses to the growing burden of diabetes. It supports WDF and its partners in embedding prevention and care into local health services and communities to help deliver lasting improvements in access.

WDF's existing partnerships show how sustained support can strengthen care. In Tanzania, more than two decades of partnership helped a small diabetes clinic develop into a nationwide programme for non-communicable diseases, owned by the government. Thousands of healthcare workers were trained, and treatment and referral guidelines were integrated into the public health system.

In Jordan, WDF and its partners integrated prevention, screening, counselling and treatment into existing services. Over five years, the programme strengthened more than 190 health facilities, trained more than 2,000 healthcare providers and improved care for more than 192,000 people, including refugees and host communities.

"The World Diabetes Foundation is grateful for this major commitment from Novo. It recognises our work over 25 years to support people living with diabetes and related non-communicable diseases in low- and middle-income countries," said Leif Fenger Jensen, Managing Director of the World Diabetes Foundation.

"Lasting improvements in health don't…

1.

Début de l'article, extrait de Yahoo Finance. Pour lire la suite, ouvrez l'article chez le média.